CL
CLVS

CSS LLC’s Clovis Oncology, Inc. CLVS Stock Holding History

CSS LLC’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,000
Closed -$35.2K – 1230
2021
Q1 		$42K Sell
6,000
-35,033
-85% -$235K ﹤0.01% 872
2020
Q4 		$197K Hold
41,033
– – 0.01% 635
2020
Q3 		$239K Hold
41,033
– – 0.01% 543
2020
Q2 		$277K Buy
+41,033
New +$311K 0.02% 450
2018
Q4 		– Sell
-6,013
Closed -$123K – 591
2018
Q3 		$177K Buy
+6,013
New +$233K 0.01% 441
2017
Q4 		– Sell
-100
Closed -$6.99K – 668
2017
Q3 		$8K Buy
+100
New +$7.93K ﹤0.01% 609
2017
Q1 		– Sell
-5,832
Closed -$355K – 758
2016
Q4 		$259K Buy
+5,832
New +$205K 0.01% 475

Other funds holding CLVS

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

CSS LLC's CLVS Position: Q2 2021 in Review

CSS LLC sold out of Clovis Oncology, Inc. (CLVS) in Q2 2021, closing a stake of 6,000 shares — an estimated $35.2K sold.

CSS LLC first reported a position in CLVS in Q4 2016 and held it in 7 quarters. The position peaked at $277K in Q2 2020. 160 funds tracked by Wall St. Rank hold CLVS as of Q2 2021.

  • CSS LLC reported no remaining Clovis Oncology, Inc. position as of Q2 2021 after selling out during the quarter.
  • CSS LLC sold 6,000 Clovis Oncology, Inc. shares in Q2 2021, an estimated $35.2K.
  • CSS LLC first reported a position in Clovis Oncology, Inc. in Q4 2016 and held it in 7 quarters.
  • CSS LLC's Clovis Oncology, Inc. position peaked at $277K in Q2 2020.
  • 160 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2021.

Based on CSS LLC's 13F filing for Q2 2021, filed 16 Aug 2021.